berberine has been researched along with glucagon in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gao, FY; Gu, JJ; Zhao, TY | 1 |
Dorfman, RG; Li, Y; Pan, Y; Tang, D; Wang, L; Xu, L; Yin, Y; Zhang, B; Zhang, M; Zhao, S; Zhou, L; Zhou, Q; Zou, X | 1 |
Jiang, B; Jin, J; Liu, P; Sheng, L; Song, Y; Zhang, H; Zhong, Y; Zhou, H | 1 |
Farhangfar, SH; Fathi Nasri, MH; Ghavipanje, N; Ghiasi, SE; Vargas-Bello-PĂ©rez, E | 1 |
1 trial(s) available for berberine and glucagon
Article | Year |
---|---|
Berberine supplementation modulates the somatotropic axis and ameliorates glucose tolerance in dairy goats during late gestation and early lactation.
Topics: Animals; Berberine; Blood Glucose; Diet; Dietary Supplements; Female; Glucagon; Glucose; Goats; Hydrocortisone; Insulin; Insulin-Like Growth Factor I; Lactation; Milk; Parturition; Pregnancy | 2022 |
3 other study(ies) available for berberine and glucagon
Article | Year |
---|---|
A preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats.
Topics: Animals; Berberine; Cells, Cultured; Diet, High-Fat; Fatty Acids, Nonesterified; Glucagon; Glucagon-Secreting Cells; Glucose Tolerance Test; Hepatocytes; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Insulin-Secreting Cells; Male; Rats; Rats, Wistar; Receptor, Insulin; Triglycerides | 2012 |
Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3.
Topics: Animals; Berberine; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Glucagon; Gluconeogenesis; Glucose; HEK293 Cells; Hepatocytes; Humans; Membrane Potential, Mitochondrial; Mice; Mice, Knockout; Oxygen Consumption; Phosphorylation; Signal Transduction; Sirtuin 3 | 2018 |
Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice.
Topics: Animals; Berberine; Diabetes Mellitus, Experimental; Glucagon; Hyperglycemia; Liver; Mice; Mice, Obese; Signal Transduction | 2020 |